Biogen Inc.
Location
Massachusetts
Founded
1978-02-28
Website
Risk Signals
6605 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Biogen Inc.
Live alerts from global media, monitored by Business Radar
2023-10-17 (pionline.com)
Companies move to settle ERISA lawsuits in third quarter
During the third quarter of 2023, 58 ERISA-related lawsuits were filed and/or updated. Each event represents the involved parties either reaching a settlement or filing an appeal, or a court decision was made.
Read more
2018-09-10 (ntvg.nl)
Secrecy is the trump card
Good news for Dutch and Belgian young children with spinal muscular atrophy (SMA): after months of negotiations and a lot of publicity, Spinraza will be included in the basic package for them from August 1. For the first time, the two countries concluded a contract with a pharmaceutical company after joint negotiations, but it is a temporary deal, lasting until 2021, and the price that both countries pay remains secret. There is therefore nothing to indicate that this joint approach will stop the price increase of new medicines.
Read more